Genetic testing company Proove Biosciences has introduced a new genetic test to help determine personalized treatment recommendations for patients with a temporomandibular joint disorder (TMD).
The Proove TMD Profile test analyzes DNA markers and integrates genetic data with stress and tender points reported by patients. The profile also helps clinician offer individualized treatment options for patients, according to the company.
